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Abstract
Membrane lipids play a pivotal role in the pathogenesis of Alzheimer’s disease, which is associated with conformational
changes, oligomerization and/or aggregation of Alzheimer’s b-amyloid (Ab) peptides. Yet conflicting data have been
reported on the respective effect of cholesterol and glycosphingolipids (GSLs) on the supramolecular assembly of Ab
peptides. The aim of the present study was to unravel the molecular mechanisms by which cholesterol modulates the
interaction between Ab1–40 and chemically defined GSLs (GalCer, LacCer, GM1, GM3). Using the Langmuir monolayer
technique, we show that Ab1–40 selectively binds to GSLs containing a 2-OH group in the acyl chain of the ceramide
backbone (HFA-GSLs). In contrast, Ab1–40 did not interact with GSLs containing a nonhydroxylated fatty acid (NFA-GSLs).
Cholesterol inhibited the interaction of Ab1–40 with HFA-GSLs, through dilution of the GSL in the monolayer, but rendered
the initially inactive NFA-GSLs competent for Ab1–40 binding. Both crystallographic data and molecular dynamics
simulations suggested that the active conformation of HFA-GSL involves a H-bond network that restricts the orientation of
the sugar group of GSLs in a parallel orientation with respect to the membrane. This particular conformation is stabilized by
the 2-OH group of the GSL. Correspondingly, the interaction of Ab1–40 with HFA-GSLs is strongly inhibited by NaF, an
efficient competitor of H-bond formation. For NFA-GSLs, this is the OH group of cholesterol that constrains the glycolipid to
adopt the active L-shape conformation compatible with sugar-aromatic CH-p stacking interactions involving residue Y10 of
Ab1–40. We conclude that cholesterol can either inhibit or facilitate membrane-Ab interactions through fine tuning of
glycosphingolipid conformation. These data shed some light on the complex molecular interplay between cell surface GSLs,
cholesterol and Ab peptides, and on the influence of this molecular ballet on Ab-membrane interactions.
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Introduction
Alzheimer’s disease is a neurodegenerative pathology of the
central nervous system currently affecting more than 25 millions of
individuals worldwide. It is characterized by the presence of
neuritic plaques and neurofibrillary tangles which contribute to
neuronal and synaptic loss. Although the molecular and cellular
mechanisms responsible for Alzheimer’s disease are not fully
understood, the formation of insoluble deposit of the b-amyloid
peptide (Ab) fragments seems to play a major role in the
pathogenesis of the disease [1,2]. What we call Ab is in fact a
family of peptides derived by the proteolytic cleavage of the
amyloid precursor protein (APP), a transmembrane protein
expressed in neuronal but also in non-neuronal tissue [3]. The
most abundant forms of Ab are 40- and 42-amino acid peptides
respectively referred to as Ab1–40 and Ab1–42. Both peptides are
found in amyloid plaques that, according to the amyloid cascade
hypothesis [2,4], eventually lead to the neurodegeneration. The
aggregation process of amyloid peptides is driven by the
supramolecular assembly of beta sheet structures. Non-fibrillar
oligomers of Ab are also toxic [5], and it is difficult to assess which
molecular species among dimers, oligomers and fibrils are the
most pathogenic.
Given that these amyloid peptides are released in the immediate
vicinity of the plasma membrane in which APP is anchored, it is not
surprising that several membrane lipids can interact with Ab and
affect the oligomerization process [6]. Lipid rafts, which are
membrane microdomains enriched in cholesterol and sphingolipids
[7], have been proposed to act as surface catalysts able to accelerate
the aggregation of Ab [8]. Ab peptides interact with several
glycosphingolipids (GSLs), including both neutral GSLs such as
asialo-GM1 [9] or galactosylceramide (GalCer) [10,11] and
gangliosides such as GM1 [12]. Conflicting data have suggested that
binding to GM1 induces either a conformational transition from
random coil to a protective a-helical structure [13] or to a fibrillation-
prone b-structure [14,15]. As a matter of fact, the structure of Ab
bound to GM1 depends on several physicochemical parameters
including pH, membrane fluidity, GM1-carrier lipid ratios, Ab
concentration, and the presence of cholesterol, which could explain
the discrepancies reported in the literature.
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Although cholesterol has been identified as a major risk factor
for Alzheimer’s disease [16], its effects on Ab fibrillogenesis and
toxicity are not well understood and the results reported so far are
controversial [17]. Cholesterol stimulates the insertion of APP into
phospholipid monolayers [18] and it binds to Ab1–42 protofibrils
[19]. However, whether cholesterol accelerates [20] or decreases
[21,22] Ab polymerization is still uncertain. Moreover, the
generation of Ab peptides through APP proteolysis occurs within
lipid rafts and is sensitive to inhibitors of cholesterol biosynthesis
[16], so that the involvement of cholesterol homeostasis in
Alzheimer’s disease cannot be simply ascribed to the regulation
of Ab fibrillogenesis.
There is one important issue that has not been addressed in these
investigations. GSLs exhibit a high biochemical diversity in both
their glycone and ceramide moieties [23]. Perhaps the most widely
neglected biochemical characteristic of GSLs in amyloid studies is
the existence of two distinct types of ceramide backbones which are
defined by the absence or presence of an OH group bound to the
C2 of the fatty acid chain [24]. Thus, major brain GSLs such as
GalCer actually exist as 2-hydroxy (2-OH) fatty acid (HFA) or non-
hydroxy fatty acid (NFA) species, in roughly equivalent amounts
[25]. The hydroxylation status of the ceramide has a major impact
on the conformation of the GSL, as elegantly demonstrated by I.
Pascher and co-workers for GalCer [26,27]. An intramolecular H-
bond network in GalCer-HFA stabilizes the parallel orientation of
the galactose ring with respect to the lipid membrane, giving the
molecule a typical L-shape [27]. In contrast, the lack of this OH
group in GalCer-NFA allows the galactose head group to freely
adopt an extended conformation in a layer-perpendicular position.
Proteins that recognize the L-shape conformation of GalCer-HFA
can totally ignore GalCer-NFA, as perfectly demonstrated for the
HIV-1 surface envelope glycoprotein gp120 [28].
Here we studied the interaction of Ab1–40 with various HFA and
NFA GSLs and the effects of cholesterol on these interactions. We
show that Ab1–40 has a marked preference for HFA vs. NFA GSLs.
This effect was reproducibly observed with both natural and synthetic
GSLs with defined fatty acid content. Cholesterol was found to inhibit
the interaction of Ab1–40 with the HFA species but to strongly
stimulate the interaction with NFA GSLs. Using a combination of
physicochemical and molecular modeling approaches, we show that
the 2-OH group of the fatty acid and the OH group of cholesterol
have a similar conformational effect on various GSLs.
Materials and Methods
Materials
Natural GalCer-NFA (kerasin), GalCer-HFA (phrenosin), GM1
and GM3 were obtained from Matreya (Pleasant Gap, PA).
Synthetic GalCer with C12:0 fatty acid chain (GalCer-C12) and
LacCer with C8:0 fatty acid chain (LacCer-C8) were purchased
from Avanti Polar Lipids (Alabaster, AL). Synthetic cholesterol
and phosphatidylserine were from Sigma (Saint-Quentin Fallavier,
France). Synthetic Ab1–40 was from Sigma. All lipids were
dissolved at a concentration of 1 mg.mL21 in hexane:chlorofor-
m:ethanol (11:5:4, vol:vol:vol). Sterile ultrapure water (endotoxin
#0.25 EU.mL21; conductivity 1.1 mS.cm21 at 20uC; resistivity
0.91 MV.cm at 20uC; surface tension 72.8 mN.m21; pH 6.9)
conditioned in 9 mL tubes was obtained from Biorad (Marnes-La-
Coquette, France). All other reagents, of the highest quality
available, were from Sigma.
Surface Pressure Measurements
Surface pressure measurements revealing peptide-lipid interac-
tions were studied by the Langmuir film balance technique with a
fully automated microtensiometer (mTROUGH SX, Kibron Inc.
Helsinki, Finland). Indeed, the interaction of a peptide (or a
protein) with a glycolipid monolayer is an interfacial phenomenon
which can be studied by surface pressure (p) measurements [6].
Namely, the insertion of the peptide in the lipid monolayer can be
detected, at constant area, by an increase in the surface pressure
(Dp). This increase in the surface pressure is caused by the
insertion of the peptide between the polar heads of vicinal
glycolipids in the monolayer, which is not counterbalanced by an
increase of the area of the monolayer. This effect can be followed
kinetically by real-time surface pressure measurements after
injecting the peptide into the aqueous subphase underneath the
lipid monolayer as described previously [29]. Such [Dp = f(t)]
curves allow to assess the actual interaction of a peptide (or a
soluble protein) with a given glycolipid. The initial velocity (vi) of
the insertion process is expressed as mN.m21.min21. The
difference between the maximal (pmax) and the initial (pi) surface
pressure values allows to calculate the maximal surface pressure
increase (Dpmax) induced by the peptide (expressed in mN.m
21).
Mixed monolayers were prepared from stock solutions of lipid
mixtures (1:1, mol:mol). Unless otherwise indicated, the subphase
underneath the lipid monolayer is ultrapure water (pH 6.9 for all
experiments). In any case, the subphase was prepared extempo-
raneously from disposable sterile units. All experiments were
conducted at 20uC in triplicate. Results were expressed as
means 6 standard deviation (S.D.).
Molecular Modeling Simulations
The structure of Ab1–40 has been retrieved from the PDB entry
# 1BA4 [30]. The structure of GSLs were derived from those
published by Pascher & Sundell [26]. The whole structure of
Ab1–40 was merged with GalCer-HFA or GalCer-NFA +
cholesterol. Molecular dynamics studies of GSLs and Ab-GSL
interactions were performed with the Hyperchem program, using
with the MM+ force field as described previously [29,31]. The
Polak-Ribiere algorithm was used to calculate the minimal energy
of the individual molecules (GSLs and peptides) in each system.
Molecular dynamics simulations were then performed for 1 ps.
The introduction of water molecules in the periodic box did not
influence the establishment of sugar-aromatic stacking interactions
[29]. Indeed, similar data were obtained when the modeling of this
interaction was performed in vacuo and in water. To improve
clarity, water molecules were not represented in the molecular
models.
Chemical Structures
All chemical structures were drawn with ChemDraw.
Results
Effect of Cholesterol on the Interaction between GalCer
and Ab1–40
In a first set of experiments we investigated the interaction of
Ab1–40 with GalCer-HFA (Figure 1a) and GalCer-NFA
(Figure 1b) purified from bovine brain (see Table 1 for a
description of the fatty acid content of the GSLs used in the
present study, and Figure 1 for GalCer structures). We used the
Langmuir monolayer technique which has been widely validated
for lipid-protein studies and has proven particularly useful for
reconstituting sphingolipid-cholesterol systems (for review, see [6]).
Monolayers of these GSLs were prepared at the air-water interface
on a subphase of ultrapure water (the use of water subphases for
such surface pressure studies has been extensively characterized
and validated in previous studies [28,29,31]). The peptide was
Cholesterol Glycolipids and Ab
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9079
injected in the subphase and the surface pressure was continuously
measured with a microtensiometer. As shown in Figure 1a, the
surface pressure started to increase immediately after the injection
of the peptide underneath the GalCer-HFA monolayer, with an
initial velocity (vi) of 0.26660.023 mN.m
21.min21 (n = 3,
Table 2). A maximal value of 12.260.9 mN.m21 (n = 3) was
reached after 65 min of interaction (Dpmax). In contrast, the
peptide interacted very weakly with a monolayer of GalCer-NFA
(Figure 1b). Following an initial slow increase (vi = 0.0336
0.004 mN.m21.min21 (n = 3, Table 2), the surface pressure
peaked after 18 min of interaction (Dpmax = 1.560.1 mN.m
21,
n = 3, Table 2). This indicates that Ab1–40 has a high affinity for
GalCer-HFA and a very low affinity for GalCer-NFA. The
presence of cholesterol in these monolayers (i.e. mixed GalCer/
cholesterol monolayers) had opposite effects for both GalCer
species. In the case of GalCer-HFA (Figure 1a), cholesterol
markedly inhibited the interaction of Ab1–40 with the monolayer
(vi = 0.03160.004 mN.m
21.min21; Dpmax = 3.260.2 mN.m
21,
n = 3, Table 2). Compared with pure monolayers of GalCer-
HFA, this corresponds to a 8.1-fold decrease in vi and a 3.8-fold
decrease in Dpmax. In contrast, cholesterol markedly stimulated the
interaction of Ab1–40 with GalCer-NFA (Figure 1b). During the
first 15 min following the injection of the peptide underneath a
mixed GalCer-NFA/cholesterol monolayer, the interaction oc-
curred with a vi = 0.10760.008 mN.m
21.min21 (n = 3, Table 2).
Then the velocity of the interaction further increased to reach
0.30860.027 mN.m21.min21 (n = 3). A Dpmax of 10.4 mN.m
216
0.6 (n = 3, Table 2) was reached after 47 min of incubation,
Figure 1. Effects of cholesterol on the recognition of GalCer-HFA and GalCer-NFA by Ab1–40. a–c. Kinetics of Ab1–40 insertion into a
monolayer of natural GalCer-HFA (a), natural GalCer-NFA (b) or GalCer-C12 (c) in either the absence (&) or presence of cholesterol (%). The pure
GalCer and mixed GalCer/cholesterol (1:1, mol:mol) monolayers were prepared at an initial surface pressure of 13–15 mN.m21 as indicated in
Materials and Methods. The data show the evolution of the surface pressure following the injection of Ab1–40 (1 mM) in the aqueous phase
underneath the monolayer. Each experiment was performed in triplicate and one representative curve is shown (S.D.,10%). The chemical structures
of GalCer-HFA (with a C18:0 2-OH fatty acid), GalCer-NFA (with a C18:0 fatty acid) and GalCer-C12 (with a C12:0 fatty acid) are shown in the lower right
panel. The stereochemistry of the C2 atom is indicated by an asterisk.
doi:10.1371/journal.pone.0009079.g001
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corresponding to a 6.9-fold increase. That the interaction
proceeded as a two-step phenomenon with an initial slow velocity
followed by a more rapid one suggests that a conformational
adjustment is required for an optimal interaction.
The data obtained with natural GalCer-NFA purified from bovine
brain were fully confirmed with synthetic GalCer-NFA, i.e. GalCer
with a C12:0 nonhydroxylated fatty acid (Figure 1c). Indeed, in
absence of cholesterol, the surface pressuremoderately increased after
the injection of Ab1–40 (vi = 0.09160.008 mN.m
21.min21, n=3,
Table 2), then reached a plateau at 2.160.1 mN.m21 (n=3,
Table 2) after 20 min and finally decreased to null values after
60 min of incubation. This decrease could be due to the secondary
release of the small amounts of peptide initially adsorbed onto the
monolayer, consistent with the low affinity of Ab for GalCer-C12. As
for natural GalCer-NFA, cholesterol stimulated the interaction
between Ab and synthetic GalCer-C12 (vi = 0.11760.009 mN.m
21.
min21; Dpmax =12.261.2 mN.m
21, n=3, Table 2). This
corresponded to a strong stimulation of Dpmax (65.8 times) with
only a minor effect on vi (61.28 times), in perfect agreement with the
data obtained with natural GalCer-NFA. Indeed, as for GalCer-
NFA, the interaction followed a two-step kinetic with an initial slow
velocity (Table 2) followed by a more rapid one
(0.20360.014 mN.m21.min21, n=3, Figure 1c).
Several control experiments were conducted with various
compositions of the lipid monolayer (Table 2). Firstly, we
demonstrated that cholesterol by itself, at the surface pressure
used in the experiments described in Figure 1 (i.e. 13–
15 mN.m21), did not interact with Ab1–40. Then we prepared
a mixed monolayer with cholesterol and an irrelevant lipid
(phosphatidylserine, PS) to ensure that the stimulating effect of
cholesterol on GalCer-NFA was specific. This was indeed the
case since in the same surface pressure range (13–15 mN.m21),
Ab1–40 did not significantly interact with PS-cholesterol
monolayers. Finally, cholesterol could also stimulate the
interaction between Ab1–40 and LacCer-C8, a synthetic form
of Galb1-4Glcb1-Cer with a C8:0 fatty acid (Figure 2). As for
GalCer-NFA and GalCer-C12, Ab1–40 showed very little
interaction with a monolayer of pure LacCer-C8. The presence
of cholesterol in the monolayer triggered the insertion of Ab, as
demonstrated by the increase in both vi (62.93) and Dpmax
(66.42) (Table 2).
Effect of Cholesterol on the Interaction between
Gangliosides and Ab1–40
Since gangliosides are known to bind to Alzheimer’s amyloid
peptides and to affect their aggregation [12,13,32,33], we studied
the effect of cholesterol on the interaction between Ab1–40 and the
monosialylated gangliosides GM3 and GM1 (Figure 3). These
gangliosides, which were purified from bovine brain (GM1) or
buttermilk (GM3), contained only NFA species (see Table 1 for
fatty acid content and Figure 3 for chemical structures). In
absence of cholesterol, both gangliosides were recognized by
Ab1–40 as shown by the kinetics of surface pressure increase after
Table 1. Typical fatty acid composition of the natural
glycosphingolipids used in this study*.
Fatty Acids GalCer-NFA GalCer-HFA GM3 GM1
C16:0 – – 6 1
C18:0 5 – 1 86
C18:1 – – – 3
C20:0 1 – 1 4
C21:0 – – 1 –
C22:0 9 – 23 2
C23:0 5 – 36 1
C24:0 25 – 22 1
C24:1 43 – 3 2
C25:0 3 – – –
C25:1 3 – – –
C26:0 2 – – –
C26:1 4 – – –
C18:0 2-OH – 36 – –
C20:0 2-OH – 1 – –
C22:0 2-OH – 8 – –
C23:0 2-OH – 6 – –
C24:0 2-OH – 25 – –
C24:1 2-OH – 9 – –
C25:0 2-OH – 4 – –
C25:1 2-OH – 2 – –
C26:0 2-OH – 2 – –
C26:1 2-OH – 2 – –
Others – 5 7 –
Total 100 100 100 100
*according to the supplier (Matreya, Pleasant Gap, PA).
doi:10.1371/journal.pone.0009079.t001
Table 2. Physicochemical parameters of the interaction
between Ab1–40 and the indicated lipid monolayers.
Lipid
Vi
(mN.m21.min21)
Dpmax
(mN.m21)
GalCer-HFA 0.26660.023 12.260.9
GalCer-HFA:cholesterol (1:1; mol:mol) 0.03160.004 3.260.2
GalCer-NFA 0.03360.004 1.560.1
GalCer-NFA:cholesterol (1:1; mol:mol) 0.10760.008 10.460.6
GalCer-C12 0.09160.008 2.160.1
GalCer-C12:cholesterol (1:1, mol:mol) 0.11760.009 12.2 61.2
Cholesterol 0.00060.000 1.060.1
PS:cholesterol (1:1, mol:mol) 0.00060.000 1.460.1
LacCer-C8 0.11460.009 2.660.2
LacCer-C8:cholesterol (1:1, mol:mol) 0.33560.028 16.761.2
GM3 0.16960.013 4.1 60.3
GM3:cholesterol (1:1, mol:mol) 0.25460.019 10.160.7
GM1 0.08560.007 6.360.6
GM1:cholesterol (1:1, mol:mol) 0.16160.014 9.860.7
GalCer-HFA subphase NaCl 0.1 M 0.55560.046 18.461.3
GalCer-HFA subphase NaCl 1 M 0.82260.077 21.361.8
GalCer-HFA subphase NaF 0.1 M 0.07860.005 3.160.2
GalCer-HFA subphase NaF 1 M 0.00060.00 0.060.0
Each monolayer was prepared at initial pressure (pi) of 13–15 mN.m
21.
The synthetic Ab1–40 peptide was injected in the subphase which consisted of
pure water or, when indicated, of NaCl or NaF solutions. Each experiment was
performed in triplicate. The data are expressed as the mean 6 SD (n = 3). An
initial vi with a null value means that there is no increase in the surface pressure
over the 20 first minutes of incubation.
doi:10.1371/journal.pone.0009079.t002
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injection of Ab1–40 underneath a monolayer of GM3 (Figure 3a)
or GM1 (Figure 3b). However, the values of Dpmax were of low
magnitude (Table 2), which indicated a moderate affinity of the
peptide for these gangliosides compared with GalCer-HFA. As for
GalCer-NFA and GalCer-C12, cholesterol had a stimulatory
effect on Ab1–40 insertion within GM3 (Figure 3a) and, although
to a lesser extent, GM1 monolayers (Figure 3b). Namely,
cholesterol induced a 2.5-fold increase for GM3 and a 1.55-fold
increase for GM1, as assessed by comparing the Dpmax values. A
detailed analysis of the kinetic parameters of these interactions is
presented in Table 2.
Overall, these data indicated that cholesterol reproducibly
facilitates the interaction of Ab1–40 with all the GSLs that have a
non-hydroxylated fatty acid. This effect was reproducibly observed
with various NFA-GSLs (GalCer-NFA, GalCer-C12, LacCer-C8,
GM3, and GM1) containing biochemically distinct fatty acids
(Table 1). On the opposite, cholesterol decreases the interaction of
Ab1–40 with GalCer-HFA. Thus the OH group linked to the C2 of
the fatty acid seems to play a critical role for Ab1–40 recognition by
GSLs, and cholesterol probably acts at this level. To unravel the
role of cholesterol on GSL conformation in the context of fatty
acid hydroxylation, we performed a series of molecular modeling
simulations.
Molecular Modeling Simulations of Cholesterol-GSL
Interactions
X-ray diffraction studies have revealed that the galactose ring of
GalCer-NFA protrudes at 180u with respect to the main axis of the
ceramide backbone [27]. Molecular dynamics studies of GalCer-
NFA remarkably converged to the same type of conformation
(Figure 4a). A remarkable fit between GalCer-NFA and
cholesterol could be found (Figure 4b), the complex being
stabilized by both van der Waals forces and H-bonds. In
particular, a H-bond network involving i) the OH group of
cholesterol, ii) the NH of sphingosine, and iii) the oxygen atom of
the glycosidic bond, could be predicted (Figure 4g–h). To better
illustrate the effect of cholesterol on the conformation of GalCer-
NFA, the GSL alone (in green) has been superimposed on the
structure of the GalCer-NFA/cholesterol complex (Figure 4d–e).
In GalCer-HFA, the 2-OH group restricts the conformation of
the galactose ring so that the molecule adopts a typical L-shape
structure (Figure 4c). This is in full agreement with crystallo-
graphic data which demonstrated that the orientation of the
galactose ring in GalCer-HFA is constrained by a network of H-
bonds involving i) the 2-OH group of the acyl chain, ii) the NH of
sphingosine, and iii) the oxygen atom of the glycosidic bond
[26,27]. This H-bond network is shown in Figure 4f which shows
the original structure of GalCer-HFA deduced from X-ray
diffraction studies [26]. Overall, these data strongly suggest that
the 2-OH group of the acyl chain and cholesterol have a
comparable conformational effect on GalCer. The molecular
mechanism is similar but a detailed analysis shows that in the case
of GalCer-HFA, the 2-OH group is a H-bond acceptor (Figure 4f)
whereas the OH group of cholesterol is a H-bond donor
(Figure 4g–h). Yet in both cases, the OH group reinforces the
strength of the H-bond between the NH group of sphingosine and
the oxygen atom of the glycosidic bond, thereby forcing the GSL
to adopt an L-shape structure.
Molecular Modeling Simulations of Ab1–40-GSL
Interactions
Our physicochemical studies (Figures 1–3) suggested that only
the OH-constrained L-shape structure of GalCer is recognized by
Ab1–40. So we performed a series of molecular modeling
simulations to investigate the possibilities of interaction between
the amyloid peptide and each type of GalCer (Figure 5). In these
experiments, we worked with the structure of Ab1–40 which has
been obtained by NMR studies of micellar systems [30]. We did
not find any significant fit for Ab1–40 and a single molecule of
GalCer-NFA. We observed that individual GalCer-NFA mole-
cules could readily form a patched structure, each galactose ring
stacked onto its neighbours (Figure 5a–b). Even in this case, there
was no obvious fit between these GalCer-NFA molecules and the
peptide. This suggests that the peptide and the GSL do not have
any geometric nor chemically compatible domains. Indeed, the
only possible mode of interaction between Ab and a cluster of
GalCer-NFA was a single H-bond which left the aromatic side
chain of residue Y10 fully exposed to the solvent (Figure 5b).
In contrast, the planar apolar surface of galactose in GalCer-
HFA [31] allowed the establishment of a coordinated CH-p
stacking interaction with the aromatic side chain of the Y10
residue (Figure 5c–d). As a consequence, the whole structure of
Ab1–40 spread onto the surface of the reconstituted GalCer-HFA
membrane. In this orientation, residues H14 and F20 are facing
the membrane, whereas residue F19 is rejected on the opposite
side. A similar interaction could also be predicted between the
conformer of GalCer-NFA constrained by cholesterol and the
Figure 2. Effects of cholesterol on the recognition of synthetic
LacCer (LacCer-C8) by Ab1–40. Upper panel: the kinetics of Ab1–40
insertion into a monolayer of synthetic LacCer-C8 (with a C8:0 fatty acid)
were measured in either the absence (&) or presence of cholesterol
(%). The pure LacCer and mixed LacCer/cholesterol (1:1, mol:mol)
monolayers were prepared at an initial surface pressure of 13–
15 mN.m21 as indicated in Materials and Methods. The data show
the evolution of the surface pressure following the injection of Ab1–40
(1 mM) in the aqueous phase underneath the monolayer. Each
experiment was performed in triplicate and one representative curve
is shown (S.D. ,10%). The chemical structure of LacCer-C8 is shown in
the lower panel.
doi:10.1371/journal.pone.0009079.g002
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amyloid peptide, through aromatic stacking with Y10 (Figure
5e–f). Overall these data suggests that both the 2-OH group of
GalCer-HFA and, in the case of GalCer-NFA, the OH group of
vicinal cholesterol, orient the sugar head of GalCer in such a way
that it becomes compatible with the establishment of CH-p
stacking interactions with aromatic amino acid side chains.
Physicochemical Experiments in Support of Molecular
Modeling Data
Several experiments were performed in order to confirm the
interpretations based on the molecular modeling studies. Firstly,
we used NaF (from 0.1 to 1M) as a breaker of H bonds, this effect
being due to the high electronegativity of the fluor atom [34]. In
presence of NaF, there was a marked inhibition of both vi and
Dpmax in the monolayer assay, showing that destabilizing the
hydrogen bond network decreased the affinity of Ab for GalCer-
HFA (Figure 6 and Table 2). Secondly, we studied the effect of
high concentrations of NaCl (from 0.1 to 1M) on the interaction
between Ab1–40 and GalCer-HFA. By increasing the ionic
strength, this salt destabilizes electrostatic interactions whereas it
reinforces hydrophobic interactions. As shown in Figure 6 and
Table 2, the presence of NaCl in the subphase resulted in a
Figure 3. Effects of cholesterol on the recognition of gangliosidesGM3 andGM1byAb1–40. Kinetics of Ab1–40 insertion into amonolayer of GM3
(a) or GM1(b) in either the absence (&) or presence of cholesterol (%). The pure ganglioside and mixed ganglioside/cholesterol (1:1, mol:mol) monolayers
were prepared at an initial surface pressure of 13–15 mN.m21 as indicated in Materials and Methods. The data show the evolution of the surface pressure
following the injection of Ab1–40 (1 mM) in the aqueous phase underneath the monolayer. Each experiment was performed in triplicate and one
representative curve is shown (S.D.,10%). The chemical structures of GM3 and GM1 (with a C18:0 fatty acid) are shown in the lower panel. Note that the
chemical structure of the glycone moiety of GM1 is derived from the one of GM3 (GM3, NeuAca2-3Galb1-4Glcb1-Cer; GM1, Gala1-3GalNacb1-4- (highlighted
in red) branched on the second Gal residue of GM3. The common oligosaccharide part shared by GM3 and GM1 is highlighted in blue.
doi:10.1371/journal.pone.0009079.g003
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marked increase in Ab1–40-GalCer-HFA association, as assessed
by both the values of vi and Dpmax. These data suggested that
hydrophobic forces, rather than electrostatic interactions, are
involved in the stabilization of the peptide-GSL complex. This is
consistent with the hydrophobic stacking interaction between the
galactose ring of GalCer and the aromatic side chain of Y10 in Ab
(Figure 5). However, the stimulatory effect of NaCl could also be
interpreted as a salting out effect of the peptide, i.e. an increased
concentration of the peptide at the interface which could change
the surface pressure independently of the association between Ab
and GalCer-HFA. To investigate this possibility, we studied the
effect of various NaCl concentrations on the spontaneous
tensioactivity of Ab1–40. In this experiment Ab1–40 (5 mM, i.e. 5
times the concentration used to study Ab-GSL interactions) was
injected in the water phase containing increasing concentrations of
NaCl (ranging from 100 to 1,000 mM). No lipid was spread at the
interface so that any change in the surface pressure reflected
exclusively the interfacial recruitment of Ab1–40. The surface
pressure increase measured after 65 min of incubation was plotted
against the NaCl concentration (Figure 7). A maximal value of
8.1 mN.m21 was obtained between 200 and 1,000 mM NaCl. At
100 mM NaCl, Ab1–40 increased the surface pressure by only
2.1 mN.m21 (to be compared with the data of Figure 6). Thus,
although the above-mentioned salting out effect did exist, it could
not, by itself, account for the stimulatory effect of NaCl on the
association between Ab1–40 and GalCer-HFA. Overall these
physicochemical data were in good agreement with the predictions
of our molecular modeling studies, which underscored the role of
hydrophobic stacking aromatic interactions (reinforced by NaCl),
and H-bonds (destabilized by NaF) in Ab-GalCer interactions.
Discussion
Although it is widely admitted that cholesterol and GSLs play a
pivotal role in Ab release, conformation, oligomerization, and
fibrillogenesis [16], the molecular mechanisms controlling the
Figure 4. Molecular modeling simulations of GalCer-HFA and GalCer-NFA (alone or complexed with cholesterol). Molecular dynamics
simulations were performed as indicated in Materials and Methods. a- GalCer-NFA; b- GalCer-NFA complexed with cholesterol (in green); c- GalCer-
HFA (the a-OH group is indicated); d- Superposition of GalCer-NFA (identical to a, colored green) with the GalCer-NFA/cholesterol complex (identical
to b). Note the distinct orientation of the galactose headgroup (Gal); e- Superposition of GalCer-NFA (in green) with GalCer-HFA; f- In GalCer-HFA, the
galactose head group is maintained in a shovel-like conformation by a network of H-bonds involving the NH of sphingosine (donor group) and the 2-
OH of the fatty acid and the oxygen atom of the glycosidic bond (both acceptor groups); g- In GalCer-NFA complexed with cholesterol, the galactose
headgroup is also maintained in a typical shovel-like conformation through a network of H-bonds involving the OH of cholesterol (donor group), the
NH of sphingosine and the oxygen atom of the glycosidic bond (both acceptor groups). h- Higher magnification of the H-bond network in GalCer-
NFA complexed with cholesterol.
doi:10.1371/journal.pone.0009079.g004
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complex interplay between Ab peptides and these lipids are not
clear. In particular, the biochemical diversity of GSLs in their
ceramide moiety, especially the hydroxylation status of the C2 in
the acyl chain, has not been appreciated in Ab-GSLs binding
studies. We believe that this issue is critical for at least three
reasons: i) quantitatively, NFA and HFA species of the same GSL
can be expressed in roughly similar amounts in brain tissues, as it is
the case for GalCer in myelin [35]; ii) the 2-OH group has a major
impact of the conformation of the GSL, due to intramolecular H-
bonding possibilities [36]; iii) gender-specific expression of NFA vs.
HFA ceramides have been observed in a mouse model of
Alzheimer’s disease, and this biochemical feature could be related
to the increased propensity of women to develop Alzheimer’s
disease [37].
Using the Langmuir monolayer technique [6], we studied the
interaction between Ab1–40 and various HFA- and NFA-GSLs
with known fatty acid composition. We showed that Ab1–40
interacted more efficiently with a pure monolayer of GalCer-HFA
than with GalCer-NFA, as assessed by both the initial velocity of
the insertion reaction and the increase in the surface pressure
induced by the peptide (Figure 1). Similar results were previously
obtained with HIV-1 gp120, a protein sharing with Ab peptides a
common sphingolipid-binding domain (SBD) involved in GalCer
recognition [10]. On the basis of these data, Hebbar et al. [11]
have designed a fluorescent SBD probe targeting lipid raft
domains on live cells. This probe, derived from the part of Ab
containing the SBD we have defined [10,38], recognized a
mixture of bovine brain GalCer containing both GalCer-HFA and
GalCer-NFA, but not synthetic GalCer-NFA. Therefore, our data
are in perfect agreement with those of Hebbar et al. [11].
Figure 5. Sugar-aromatic CH-p stacking interactions between
Ab1–40 and GalCer-HFA or GalCer-NFA complexed with choles-
terol. Molecular dynamics simulations were performed as indicated in
Materials and Methods. a- View of a cluster of 4 GalCer-NFA molecules
in a plasma-membrane compatible orientation. Interactions in both the
polar and apolar parts of the GSL stabilize the complex. The dotted line
indicates the polar-apolar interface. b- The same cluster of GalCer-NFA
molecules shown in (A) has been merged with Ab1–40 (PDB entry #
1BA6) to search for potential interactions between Ab and GalCer-NFA.
No obvious fit could be found, the only predicted interaction being the
H-bond between the phenolic OH group of Y10 and the CH2OH group
of one of the galactose rings. Note that the aromatic side chain of Y10
cannot stack onto any galactose ring, none being accessible. The
stacking of the galactose headgroups of vicinal GalCer-NFA molecules
(Gal-Gal stacking) is indicated by an arrow. c- CH-p stacking interaction
between the galactose ring of GalCer-HFA and the aromatic side chain
of the Y10 residue in Ab1–40. Note that the peculiar geometry of the
complex leaves residues H14 and F20 accesible for complementary
interactions with membrane lipids, whereas residue F19 is rejected on
the opposite side. d- Detailed view of the complex between GalCer-
HFA and Ab (to improve clarity only residues 8–22 of Ab1–40 are shown).
The perfect geometry of the CH-p stacking interaction between the
galactose ring and the aromatic side chain of Y10 is illustrated in the
inset. e- In presence of cholesterol (Chol), the galactose headgroup of
GalCer-NFAadopts a specific conformation which renders the galactose
ring accessible for a CH-p stacking interaction with the Y10 residue of
Ab1–40. f- Detailed view of the complex between cholesterol, GalCer-
NFA, and Ab (residues 8–22 of Ab1–40). The CH-p stacking interaction
and the H-bond network stabilizing the active conformation of GalCer-
NFA are shown.
doi:10.1371/journal.pone.0009079.g005
Figure 6. Effects of sodium salts on the interaction between
GalCer-HFA and Ab1–40. Monolayers of GalCer-HFA were prepared at
an initial surface pressure of 13–15 mN.m21 on a subphase of pure
water (&), 0.1 M NaCl (#) or 0.1 M NaF (n). The data show the
evolution of the surface pressure following the injection of Ab1–40
(1 mM) in the subphase. Each experiment was performed in triplicate
and one representative curve is shown.
doi:10.1371/journal.pone.0009079.g006
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In the present study, the interaction of Ab1–40 with lipid
monolayers has been performed at a surface pressure (13–
15 mN.m21) that is lower than the value of 30 mN.m21 currently
considered as representative of natural membrane bilayers [39].
The rationale for working at 13–15 mN.m21 is that at these
pressures, Ab1–40 does not penetrate into pure cholesterol
monolayers (Table 2). This allows a clear-cut assessment of the
effect of cholesterol on the interaction of Ab1–40 with various
natural and synthetic GSL species. Previous data indicated that
Ab1–40 readily interacts with a monolayer of GalCer-HFA with an
initial surface pressure of 30 mN.m21 [10]. In contrast, under the
same conditions, the peptide showed very little interaction with
GalCer-NFA and GalCer-C12 monolayers (data not shown).
Therefore, one of the most important findings of the present study
(strong interaction of Ab1–40 with GalCer-HFA monolayers, weak
interaction with GalCer-NFA and GalCer-C12) was confirmed at
high surface pressure values that are representative for natural
biomembranes.
The other major finding of this study is that cholesterol could
transform the inactive GalCer-NFA into a fully active GSL-
cholesterol complex recognized by Ab1–40. This stimulatory effect
of cholesterol was observed with both natural and synthetic
GalCer-NFA (Table 2). Control experiments with cholesterol
alone and with PS:cholesterol mixed monolayers confirmed that
the peptide specifically recognized GalCer-NFA complexed with
cholesterol (Table 2). The previously established 3D structures of
GalCer-NFA and GalCer-HFA [26] immediately suggests a
molecular mechanism accounting for these physicochemical data.
In GalCer-HFA, the galactose ring is parallel to the membrane,
consistent with the establishment of a typical CH-p stacking
interaction [40] between the apolar face of galactose and an
aromatic side chain of the peptide [29]. This type of interaction
has been evidenced for various sugar-protein complexes, including
sugar-lectin and GSL-peptide systems [41]. Structure similarity
searches combined with various physicochemical approaches
suggested that the interaction between GalCer-HFA and Ab
involved the aromatic side chain of Y10 [10]. Interestingly Hebbar
et al. [11] who showed that a double mutant Ab peptide (R5A/
Y10A) did not bind to GalCer. Altogether, these data are in line
with the molecular modeling study of Figure 5, in which we
assigned a major role for Y10 in GalCer recognition. We conclude
that the binding of Ab to GalCer requires that the galactose ring of
the GSL is in a parallel orientation with respect to the membrane,
the GSL adopting a typical L-shape. This conformation can be
stabilized by an intramolecular H-bond network involving the 2-
OH group of GalCer-HFA. In absence of this H-bond network,
GalCer-NFA cannot adopt this active conformation (Figures 4–
5). The galactose rings are not accessible to the Y10 residue, and
there is no possibility for a stable interaction with Ab. Yet
cholesterol can transform this inactive conformation by forcing the
galactose ring to adopt a parallel orientation compatible with the
stacking of Y10. As expected, this hydrophobic CH-p stacking
interaction was reinforced in presence of high concentrations of
NaCl in the subphase underneath the monolayer (Figure 6 and
Table 2). Finally, destabilizing the intramolecular H-bond
network with NaF strongly impaired the insertion of Ab, which
strongly supported the conclusions drawn on the basis of our
modeling studies. In total agreement with our data, Ikeda &
Matsuzaki [42] also identified H-bonding and hydrophobic
interactions as the driving forces responsible for Ab1–40-glycolipid
interactions in lipid bilayer systems.
The specific effect of cholesterol on GSL conformation is not
necessarily related to the condensing activity of the sterol on GSL
monolayers. Indeed, comparative studies of mixed monolayers
suggested that at 22uC, cholesterol displays a high condensing
effect on dihexosylceramides, but on GalCer monolayers [43]. At
37uC, cholesterol was found to specifically condense GalCer-NFA,
but not GalCer-HFA [24]. Thus our data cannot be interpreted in
terms of cholesterol-induced condensation of GSL species, but
definitely in terms of GSL conformation, which can be finely
tuned by vicinal cholesterol molecules. That the incorporation of
cholesterol in a GalCer-NFA monolayer could modulate the
average orientation of the sphingolipid is in line with the
subsequent studies of GalCer-cholesterol interactions conducted
by Smaby et al. [44].
Finally, the regulatory activity of cholesterol on the conforma-
tion of GSL and the resulting impact on Ab recognition was also
observed for more complex GSLs such as LacCer, GM3 and
GM1. This suggests that cholesterol exerts a wide regulatory
activity on Ab-GSL interactions, whose direction depends on the
hydroxylation status of the fatty acid chain of the GSL: stimulation
of Ab binding for NFA-GSLs, inhibition of Ab binding for HFA-
GSLs. That ‘‘variations in GSL fatty acid composition may
mediate aglycone regulation of GSL membrane receptor function
by a differential interaction with cholesterol and other membrane
components’’ has been recently discussed by Lingwood et al. [45].
As stated above, fatty acid hydroxylation of GSLs is generally
associated with improved ligand binding [11,28,29,46–48], and
this effect has been correlated with the conformation of the sugar
head group of GSLs based on the crystallographic studies
published by Pascher and co-workers [26,27]. In line with all
these studies, our data demonstrate that the ceramide part of GSLs
is critical for Ab binding, and that cholesterol can, for those GSLs
which are normally not recognized by Ab (i.e. NFA-GSLs), forces
them to adopt a conformation compatible with Ab. This fine
tuning of GSL conformation may be highly relevant to the
neuropathology of Alzheimer’s disease.
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Figure 7. Change in surface pressure as a function of time upon
injection of Ab1–40 into a water subphase containing various
NaCl concentrations. The concentration of Ab1–40 in the subphase is
5 mM and the subphase temperature is 20uC. The results are expressed
as the mean 6 S.D. of three independent surface pressure measure-
ments performed after 65 min of incubation with the peptide.
doi:10.1371/journal.pone.0009079.g007
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